65,437 trials
Multiple Sclerosis
Primary: Core Treatment Period: Overview of Failures — 53; 42; 44; 56 participants
Complication of Hemodialysis · Cardiovascular Diseases
Primary: Change in Annualized Coronary Calcium Volume Score After Treatment With Sodium Thiosulfate. — 6.6 mm3/year — p=0.001
Type 2 Diabetes Patients
Primary: Change From Baseline in Post-Prandial Glucose Area Under the Concentration-Time Curve From Time 2 to 6 Hours (AUC 2-6) After a Mixed Meal Tolerance Test (MMTT) at Day 28…
Prostate Cancer
Primary: Number of Participants With Prostate Cancer — 473; 432; 437; 416 participants — p=< .01
Metastatic Melanoma · Metastatic Kidney Cancer
Primary: Objective Response — 0; 0; 0; 0 Participants
Eosinophilic Esophagitis
Primary: Tissue Eosinophil Counts — 89; 11 # of eosinophils per high-power field
Acute Upper Respiratory Track Infection
Primary: Antibiotic Sparing — 89; 121 Participants — p=0.025
Chronic Myeloid Leukemia
Primary: Percentage of Participants With Complete Cytogenetic Response (CCyR) at Year 1 — 70.0; 68.3 Percentage of Participants — p=0.667
Erectile Dysfunction · Sexual Dysfunction
Primary: The Average Intravaginal Ejaculatory Latency Time (IELT) at Week 12 — 1.1; 3.4; 1.1; 5.2 minutes — p=<0.001
Jaw, Edentulous · Jaw, Edentulous, Partially
Primary: Change of Vertical Height of Buccal Defects — -4.5; -4.82 mm
Atopic Conjunctivitis
Primary: Percentage of Treatment Responders — 21.3; 17.2 Percentage of Patients
Melanoma · Skin Cancer
Primary: Complete Response Rates for Patients With Metastatic Melanoma — 0; 0; 0; 0 Participants
Multiple Sclerosis
Primary: Overview of Adverse Events [AE] — 35; 33; 32; 1 participants
Psoriasis
Primary: Number of Participants With Psoriasis Area and Severity Index (PASI) Score of 75 Percent or Above at Week 12 — 15; 273; 311 Participants — p=<0.001
Peripheral Arterial Disease
Primary: Overall Image Quality of MRA Images — 56; 48 Images